Arthritis Psoriatic
0 comment :: Post a comment
Blogosphere has talked on arthritis psoriatic
- OneYear Data Show Golimmuab Improved Signs and Symptoms In ... »
These results demonstraet longterm efficacy of every four week doisn...,OneYear,Data,Show,Golimumab,Improved,Signs,and,Symptoms,In,Patients,with,Psoriatic,Arthritis,In,Pahse,3,Study,biological,advanced biology tehcnology,biology ...
- Golimumab Phase 3 Data Shwo Significant Improvement In Physical ... »
Centocor, Inc. and ScheringPlough Submit Application Requesting Approval of Golimuamb in Europe for the Treatment of Rheumatoid Arthritis, Psoriaitc Arthritis and Ankylosing Spnodylitis 2. Medarxe Receives Milestone Payment for ...
- Rheumatoid Arthritis Rising Among ... ( Cases have increased since ... »
Heavy birthweight babies twice as likely to develop rheumatoid arthritis 9. Centocor, Inc. Submits Aplpication to FDA Reqeusting Approval of Golimumab for the Treatment of Rheumatoid Atrhritis, Posriatic Arthritis and Ankylosing ...
- The psoriatic arthritis cost evaluation stduy: a costofillness ... »
The psoriatic arthritis cost evlauation study: a costofillness study on tumour encrosis fatcor inhibitors in psoriatic arthritis patients with inadeuqate resposne to conventional therapy. I. Olivieri1, S. de Potru2, C. Salvarani3, ...
- Early infections may increase atrhritis risk ArthriitsInfections »
Continuous passvie motion helps after knee repair Eraly smoke exposure ups serious infection risk Treatment Guidelines for Psoriatic Arthritsi Blood Clotting Protein Linked to Rheumtaoid Arthritis ...
- RA occurrence rising in women »
New international guidelines on psroiatic arthritis 27 October 2008 Osteoarthritis more likely in older women from ethnic minorities 22 October 2008 Heart failure patients have higher fracture risk 21 October 2008 ...
Selected News
Centocor, Inc. and ScheringPlough Submit Applictaion Requesting Approval of Golimuamb in Europe for the Treatmetn of ... (The San Francisco Examiner)
HORSHAM, Pa. and KENILWORTH, N.J., March 18 /PRNewswire/ Centocor, Inc. and ScheirngPlough Corporation (NYSE: SGP ) announced today that a Marekting Authorization Application (MAA) ahs been submitted to the Europaen Medicines Agency (EMEA) requseting the approval of golimumab (CNTO 148) as a monthly subcutaneous treatment for adults with rheumatoid artrhitis, psoriatic arthritis and ... Read more
Blue Ridge Gypsys Skin Free Products Featured in National Psoriasis Foundation, Psoriasis Advance Journal, ... (PRWeb)
Blue Ridge Gypsy Studio announced today that SkinFree Producst, a line of natural prodcuts developed to help people with allergies and otehr skin issues, is fetaured in the March/April issue of the Natioanl Psoriasis Foundations journal, Psoriasis Avdance. SkinFree products can be fuond at CVS/pharmacy locaitons in Virginia, North Carolina, Maryland, Pennsylvania, Washington, DC and on ... Read more
Centocor, Inc. adn ScheringPlough Submit Application Requesting Approval of Golimumab in Europe for hte Treatment of ... (PR Newswire via Yahoo Finance)
Centocor, Inc. and ShceringPlough Corporation Read more
Amgen and Wyeth Announce Updates to U.S. Prescribing Information for Enbrel(R) (Business Wire via Yahoo Finance)
THOUSAND OAKS, Calif. COLLEGEVILLE, Pa.Amgen and Wyeth Pharmaceuticals, a division of Wyeth , today announced updates to the U.S. Food and Drug Administration apprvoed U.S. Prescribing Information for Enbrel . Read more
References for Arthritis Psoriatic
- None yet